论文部分内容阅读
子宫肌瘤是女性生殖器官最常见的良性肿瘤,是妇科手术排位第一的疾病。随着腹腔镜技术的普及,越来越多的子宫肌瘤剔除术及全子宫切除术可以通过腹腔镜完成。标本的取出多数使用电动子宫肌瘤粉碎器通过套管针将标本粉碎后完成,2014年美国食品与药品管理局(FDA)关于电动子宫肌瘤粉碎器应用的通告引发妇产科业内激烈震动及热议,如何正确理解和看待FDA的通告,尚未有共识和相关指南出台,所以临床上各国处
Uterine fibroids are the most common benign tumors of female genital organs, which is the number one disease in gynecological surgery. With the popularity of laparoscopic techniques, more and more myomectomy and hysterectomy can be done by laparoscopy. The majority of specimens were removed using an electrodynamic uterine fibroaner through a trocar and the notification was completed in 2014. The US Food and Drug Administration (FDA) circular on the application of electric uterine fibroaner shredding caused intense vibration in the gynecology and obstetrics profession and Hot debate, how to correctly understand and treat the FDA’s notice, there is no consensus and the introduction of relevant guidelines, so clinically all countries